Those with remission at preadolescence have lower lifetime use of antipsychotics and intensive mental health interventions
Read More »HealthDay.com
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes
Read More »15.6 Million Lifetime Gastric Cancers Expected in Those Born During 2008 to 2017
58 percent of cases expected in traditionally high-incidence areas; 42 percent expected to occur in lower-incidence areas
Read More »Varying Associations ID’d Between Hormone Therapy, Young-Onset Breast Cancer
Inverse link seen for estrogen hormone therapy use and young-onset breast cancer; positive link seen for long-term use of estrogen plus progestin hormone therapy
Read More »Almost 15 Percent of U.S. Seniors Use Aspirin for Primary Prevention
22.7 percent of primary prevention aspirin users started aspirin without a physician's recommendation
Read More »Nontargeted Screening Approach Better for Identifying New Hep C Infection in ED
Small proportion of those newly diagnosed were linked to follow-up care and attained sustained virologic response at 12 weeks
Read More »Radiation Therapy Can Promote Amphiregulin, Which Increases Growth of Metastases
Patients whose tumors expressed increased amphiregulin had shorter progression-free and overall survival
Read More »Many Indicators of Anger Expression Decrease With Age in Women
Study found Anger Temperament, Anger Reaction, Anger Expressed Aggressively, Hostility subscales on STAXI each decreased significantly with age
Read More »Susan Monarez Advances in Process to Lead CDC
By I. Edwards HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) — Susan Monarez is one step closer to becoming the next director of the U.S. Centers for Disease Control and Prevention (CDC).On Wednesday, the U.S. Senate’s health committee voted 12-11 to move her nomination forward. The vote was along party …
Read More »Hypercholesterolemia Treatment Falls Short of Guidelines
In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.